Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00187122 · ClinicalTrials.gov registry record · NA
Treatment for Patients With Stage III or IV Non-Hodgkin Lymphoma
A NA study, sponsored by St. Jude Children's Research Hospital.
- Completed
- Registry status
- NA
- Development phase
- 42
- Enrollment target
NCT00187122 is a NA study that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 42 participants.
The verdict
NCT00187122, a NA study, has completed, sponsored by St. Jude Children's Research Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
Study Summary
The main purpose of this study is to determine if it is feasible to administer an intensified, multi-agent chemotherapy regimen for children with stage III and IV non-Hodgkin lymphoma and to find out what the toxicities are.
Interventions
- DRUG Vincristine
- DRUG Cytarabine
- PROCEDURE Radiation Therapy
- DRUG Daunomycin
- DRUG L-Asparaginase
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 1993-03 |
| Est. Completion | 2004-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00187122
The ClinicalTrials.gov registry entry for NCT00187122 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Vincristine is the first listed.
NCT00187122 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00187122 about?
NCT00187122 is a clinical study titled "Treatment for Patients With Stage III or IV Non-Hodgkin Lymphoma". The main purpose of this study is to determine if it is feasible to administer an intensified, multi-agent chemotherapy regimen for children with stage III and IV non-Hodgkin lymphoma and to find out what the toxicities are.
What is the current status of trial NCT00187122?
This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 1993-03. Estimated completion is 2004-06.
What interventions are being tested in trial NCT00187122?
The interventions under investigation include: Vincristine (DRUG), Cytarabine (DRUG), Radiation Therapy (PROCEDURE), Daunomycin (DRUG), L-Asparaginase (DRUG).
Who is sponsoring clinical trial NCT00187122?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.